Skip Ribbon Commands
Skip to main content

NaviTrack

NaviCrossTM Support Catheter is dedicated to reach and cross complex lesions in challenging anatomy. 


Available in 0.035’’ and 0.018’’ wire compatibility, NaviCrossTM supports your success in both femoro-popliteal and below-the-knee interventions. 

The addition of Radifocus Glidewire Advantage TrackTM to your toolkit provides with additional performance, for the most challenging cases.  

The addition of an extra-stiff stainless-steel proximal core shaft makes a guidewire that easily navigates, while providing with excellent pushability and support  

Available in 0.018’’ and 0.014’’ sizes, Radifocus Glidewire Advantage TrackTM supports your success in both, femoro-popliteal and below-the-knee interventions 

  1. Boulton AJM, Vileikyte L, Ragnarson-Tennvall G, et al. The global burden of diabetic foot disease. Lancet. 2005;336:1719-1724.

  2. Faglia E, Clerici G, Clerissi J, et al. Early and five-year amputation and survival rate of diabetic patients with critical limb ischemia: data of a cohort study of 564 patients. Eur J Vasc Endovasc Surg. 2006;32:484-490.

  3. Ferraresi R, Palena LM, Mauri G, et al. Tips and tricks for a correct endo approach. J Cardiovasc Surg. 2013;54:685-711.

  4. Faglia E, Dalla Paola L, Clerici G, et al. Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg. 2005;29:620-627.

  5. Palena LM, Manzi M, Retrograde Transmetatarsal Artery Access: Below-the-ankle angioplasty for foot preservation in CLI patients. Endovasc Today. 2014

  6. Michael S. Conte et al. Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia. Eur J Vasc Endovasc Surg (2019) 58, S1-S109.

What the evidence says

Discover our clinical evidence and case studies concerning this topic.

Do you need more info about this product?

Our sales representatives are here for you.

Contact us
Send us a message
 
I have read and accept Terumo Privacy And Cookies Policy and the Terms Of Use*
I wish to receive information and marketing updates from Terumo.
* mandatory fields

Thank you for contacting us!

We typically respond within 2 business days and will come back to you as soon as possible.

Are you a healthcare professional?

This webpage can include promotional content regarding one or several products of Terumo Europe, or some procedures concerning the use or implantation of such products. This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public


For Pharmaceutical Professionals interested in our B2B products portfolio, please visit Terumo Pharmaceutical Solutions.